We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
GenMark Diagnostics Inc | NASDAQ:GNMK | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.05 | 23.92 | 24.39 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
(Rule 14d-101)
Solicitation/Recommendation Statement
Under Section 14(d)(4) of the Securities Exchange Act of 1934
GENMARK DIAGNOSTICS, INC.
(Name of Subject Company)
GENMARK DIAGNOSTICS, INC.
(Name of Persons Filing Statement)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
372309104
(CUSIP Number of Class of Securities)
Scott Mendel
Chief Executive Officer
GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad, CA 92008
(760) 448-4300
(Name, address and telephone numbers of person authorized to receive notice and communications
on behalf of the persons filing statement)
With a copy to:
Michael Kagnoff, Esq.
Patrick OMalley, Esq.
4365 Executive Drive, Suite 1100
San Diego, CA 92121
(858) 677-1400
☒ |
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
The information set forth under Items 7.01 and 9.01 of the Current Report on Form 8-K filed by GenMark Diagnostics, Inc. on March 15, 2021 (including all exhibits attached thereto) is incorporated herein by reference.
1 Year GenMark Diagnostics Chart |
1 Month GenMark Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions